Mass balance in rapamycin autoxidation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 5, 2008, Pages 1368-1374

  Oyler, Alan R ^a   Armstrong, Barbara L ^b   Dunphy, Richard ^b   Alquier, Lori ^c   Maryanoff, Cynthia A ^c   Cohen, Judith H ^c   Merciadez, Mel ^c   Khublall, Ada ^c   Mehta, Rajshekhar ^c   Patel, Ashesh ^c   Il'ichev, Yuri V ^c  

^a UNIVERSITY OF MINNESOTA DULUTH   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

Autoxidation; Mass balance; Rapamycin; RP HPLC; SEC

Indexed keywords

MONOMER; OLIGOMER; RAPAMYCIN;

ARTICLE; AUTOOXIDATION; DRUG DEGRADATION; DRUG OXIDATION; GEL PERMEATION CHROMATOGRAPHY; PRIORITY JOURNAL; REFRACTION INDEX; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET IRRADIATION; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMERIZATION; DRUG-ELUTING STENTS; IMMUNOSUPPRESSIVE AGENTS; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; REFRACTOMETRY; SIROLIMUS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 58149522917     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.09.030     Document Type: Article

References (44)

1. Guidance for Industry Q1A(R2) Stability Testing of New Drug Substances and Products. U.S. Department of Health and Human Services Food and Drug Administration (CDER; CBER), November 2003 ICH Revision 2.
2. Bakshi M., and Singh S. J. Pharm. Biomed. Anal. 28 (2002) 1011-1040
3. In: Baertschi S.W. (Ed). Drugs and the Pharmaceutical Sciences Volume 153, Pharmaceutical Stress Testing, Predicting Drug Degradation (2005), Taylor & Francis, New York
4. Jackson R.A. Am. Pharm. Rev. 10 (2007) 59-79
5. Ruan J., Tattersall P., Lozano R., and Shah P. Am. Pharm. Rev. 9 (2006) 46-53
6. M. Nussbaum, P.J. Jansen, S.W. Baertschi, in Ref. [3], pp. 181-204.
7. Hofer J.D., Olsen B.A., and Rickard E.C. J. Pharm. Biomed. Anal. 44 (2007) 906-913
8. Lukulay P., and Hokanson G. Pharm. Technol. 29 (2006) 106-112
9. Nussbaum M.A., Baertschi S.W., and Jansen P.J. J. Pharm. Biomed. Anal. 27 (2002) 983-993
10. Koerner A. LCGC N. Am. 20 (2002) 364-373
11. Lutzhoft H.-C.H., Foged C., Rasmussen S.R., Lehmann S., and Olsen H. J. Pharm. Sci. 93 (2004) 1142-1153
12. Jin X., Yang X., Yang L., Liu Z.-L., and Zhang F. Tetrahedron 60 (2004) 2881-2888
13. Smith G.B., DiMichele L., Colwell Jr. L.F., Dezeny G.C., Douglas A.W., Reamer R.A., and Verhoeven T.R. Tetrahedron 49 (1993) 4447-4462
14. Mordi R.C., Walton J.C., Burton G.W., Hughes L., Ingold K.U., Lindsay D.A., and Moffatt D.J. Tetrahedron 49 (1993) 911-928
15. Oyler A.R., Motto M.G., Naldi R.E., Facchine K.L., Hamburg P.F., Burinsky D.J., Dunphy R., and Cotter M.L. Tetrahedron 45 (1989) 7679-7694
16. Morita M., and Tokita M. Lipids 41 (2006) 91-95
17. Morita M., and Tokita M. Lipids 43 (2008) 589-597
18. Luna P., de la Fuente M.A., Salvador D., and Marquez-Ruiz G. Lipids 42 (2007) 1085-1092
19. Schneider C., Boeglin W.E., Yin H., Porter N.A., and Brash A.R. Chem. Res. Toxicol. 21 (2008) 895-903
20. Schneider C., Porter N.A., and Brash A.R. J. Biol. Chem. 283 (2008) 15539-15543
21. Pajunen T.I., Johansson M.P., Hase T., and Hopia A. Lipids 32 (2008) 599-610
22. Hovorka S.W., and Schoneich C. J. Pharm. Sci. 90 (2001) 253-269
23. Ingold K.U. Acc. Chem. Res. 2 (1969) 1-9
24. Clark K.B., Howard J.A., and Oyler A.R. J. Am. Chem. Soc. 119 (1997) 9560-9561
25. Howard J.A. In: Alfassi Z.B. (Ed). Peroxyl Radicals (1997), Wiley, Chichester, UK 283-334
26. Ramcharitar S., Vaina S., and Serruys P.W. Am. J. Cardiovasc. Drugs 7 (2007) 81-93
27. Abizaid A. Vascular Health and Risk Management 3 (2007) 191-201
28. Curfman G.D. N. Engl. J. Med. 346 (2002) 1770-1771
29. Suzuki T., Kopia G., Hayashi S.-i., Bailey L.R., Llanos G., Wilensky R., Klugherz B.D., Papandreou G., Narayan P., Leon M.B., Yeung A.C., Tio F., Tsao P.S., Falotico R., and Carter A.J. Circulation 104 (2001) 1188-1193
30. T. Zhu, United States Patent No. US 6,399,625 B1, June 4, 2002 (Chem. Abstr. 136 (2002) 294672).
31. Marquez-Ruiz G., Holgado F., Garcia-Martinez M.C., and Dobarganes M.C. J. Chromatogr. A 1165 (2007) 122-127
32. Marquez-Ruiz G., Perez-Camino M.C., and Dobarganes M.C. J. Chromatogr. 514 (1990) 37-44
33. Burkow I.C., and Henderson R.J. J. Chromatogr. 552 (1991) 501-506
34. Lopez-Serrano M., and Barcelo A.R. J. Chromatogr. A 919 (2001) 267-273
35. Li P., Coleman D.W., Spaulding K.M., McClennen W.H., Stafford P.R., and Fife D.J. J. Chromatogr. A 914 (2001) 147-159
36. Mansouri E.E., Yagoubi N., and Ferrier D. J. Chromatogr. A 771 (1997) 111-118
37. Schwald W., Concin R., Bonn G., and Bobleter O. Chromatographia 20 (1985) 35-40
38. G. Boccardi, in Ref. [3], pp. 205-234.
39. Nelson E.D., Harmon P.A., Szymanik R.C., Teresk M.G., Li L., Seburg R.A., and Reed R.A. J. Pharm. Sci. 95 (2006) 1527-1539
40. Waterman K.C., Adami R.C., Alsante K.M., Hong J., Landis M.S., Lombardo F., and Roberts C.J. Pharm. Dev. Technol. 7 (2002) 1-32
41. Zhang B., Li X., and Yan B. Anal. Bioanal. Chem. 390 (2008) 299-301
42. Striegel A.M. Anal. Bioanal. Chem. 390 (2008) 303-305
43. Wu C. Handbook of Size Exclusion Chromatography and Related Techniques. Second Edition (2004), Marcel-Dekker, New York
44. S.S. Hang, in Ref. [43], pp. 481-499 (Chapter 17).